S1418/BR006, A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with greater than 1 cm Residual Invasive Cancer or Positive Lymph Nodes (greater than pN1mic) After Neoadjuvant Chemotherapy.
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
Greeley Campus
Harmony Campus
Highlands Ranch Hospital
Lone Tree Medical Center
Medical Center of the Rockies
Memorial Hospital Central
Memorial Hospital North
Poudre Valley Hospital
University of Colorado Hospital
Study ID
Protocol Number: 16-2594
More information available at ClinicalTrials.gov: NCT02954874
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers